Response rate of hepatitis C patients treated with high dose Interferon Alfa 2a with Ribavirin and Interferon Alfacon-1 with Ribavirin.

被引：0
|
作者：
Islam, KK
Sokhi, RP
Kim, KS
Nadir, A
Shah, N
Harig, JM
Van Thiel, DH
机构：
[1] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
[2] Howard Univ Hosp, Washington, DC USA
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1796
引用
收藏
页码：621A / 621A
页数：1
相关论文
共 50 条
  • [1] Efficacy of interferon alfacon-1 in nonresponders and relapsers to interferon and ribavirin.
    Sjogren, MH
    Wu, G
    Herrine, S
    Raufman, JP
    Bacon, B
    Epstein, M
    Medoff, J
    Chen, S
    Waters, B
    Krawitt, E
    Herrera, J
    GASTROENTEROLOGY, 2000, 118 (04) : A1489 - +
  • [2] Interferon alfacon-1 and ribavirin versus interferon α-2b and ribavirin in the treatment of chronic hepatitis C
    Sjogren, MH
    Sjogren, R
    Holtzmuller, K
    Winston, B
    Butterfield, B
    Drake, S
    Watts, A
    Howard, R
    Smith, M
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (04) : 727 - 732
  • [3] Interferon Alfacon-1 and Ribavirin Versus Interferon α-2b and Ribavirin in the Treatment of Chronic Hepatitis C
    Maria H. Sjogren
    Robert Sjogren
    Kent Holtzmuller
    Bradley Winston
    Betty Butterfield
    Stanley Drake
    Amber Watts
    Robin Howard
    Milton Smith
    Digestive Diseases and Sciences, 2005, 50 : 727 - 732
  • [4] Retreatment of Chronic Hepatitis C with Interferon Alfacon-1/Ribavirin after Nonresponse to Pegylated Interferon/Ribavirin in Veterans
    Patel, Nehali
    Suman, Amitabh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S100 - S101
  • [5] High-dose interferon alfacon-1 is a treatment option for non-responders and relapsers to combined therapy with interferon and ribavirin.
    Sjogren, MH
    Wu, G
    Herrine, SK
    Raufman, JP
    Bacon, BR
    Epstein, M
    Medoff, J
    Chen, S
    Waters, B
    Krawitt, E
    Sjogren, RW
    Herrera, J
    HEPATOLOGY, 2000, 32 (04) : 352A - 352A
  • [6] Retreating Chronic Hepatitis C with Daily Interferon Alfacon-1/Ribavirin After Nonresponse to Pegylated Interferon/Ribavirin: DIRECT Results
    Bacon, Bruce R.
    Shiffman, Mitchell L.
    Mendes, Flavia
    Ghalib, Reem
    Hassanein, Tarek
    Morelli, Giuseppe
    Joshi, Shobha
    Rothstein, Kenneth
    Kwo, Paul
    Gitlin, Norman
    HEPATOLOGY, 2009, 49 (06) : 1838 - 1846
  • [7] EFFICACY OF DAILY DOSE CONSENSUS INTERFERON ALFACON-1 (CIFN) AND RIBAVIRIN IN PREVIOUS NON RESPONDERS TO PEGYLATED INTERFERON AND RIBAVIRIN IN PATIENTS WITH ADVANCED FIBROSIS FROM CHRONIC HEPATITIS C
    Mantry, Parvez S.
    Barnes, Maisha
    HEPATOLOGY, 2008, 48 (04) : 893A - 894A
  • [8] Consensus interferon in combination with ribavirin for hepatitis C patients with nonresponse or relapse to interferon alpha and ribavirin.
    Buggisch, P
    Hinrichsen, H
    Hueppe, D
    Reiser, M
    Kueppers, H
    Wursthorn, K
    Sterneck, M
    HEPATOLOGY, 2001, 34 (04) : 590A - 590A
  • [9] Re-Treating Chronic Hepatitis C with Daily Interferon Alfacon-1/Ribavirin After Nonresponse to Pegylated Interferon/Ribavirin: Really Safe and Effective?
    Lo, Gin-Ho
    HEPATOLOGY, 2009, 50 (03) : 988 - 988
  • [10] Elevated hepatic transaminases associated with the use of interferon alfacon-1 and ribavirin
    Kleppinger, Erika L.
    Ragan, Addison P.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (05) : 465 - 468
12345